Zydus Wellness Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1557.05
- Today's High:
- ₹1604.45
- Open Price:
- ₹1586.4
- 52W Low:
- ₹1359.3129
- 52W High:
- ₹1785.1914
- Prev. Close:
- ₹1588.25
- Volume:
- 3171
Company Statistics
- Market Cap.:
- ₹103.20 billion
- Book Value:
- 805.041
- Revenue TTM:
- ₹22.60 billion
- Operating Margin TTM:
- 12.44%
- Gross Profit TTM:
- ₹10.96 billion
- Profit Margin:
- 12.55%
- Return on Assets TTM:
- 3.39%
- Return on Equity TTM:
- 6.23%
Company Profile
Zydus Wellness Limited had its IPO on under the ticker symbol ZYDUSWELL.
The company operates in the Consumer Defensive sector and Packaged Foods industry. Zydus Wellness Limited has a staff strength of 975 employees.
Stock update
Shares of Zydus Wellness Limited opened at ₹1586.4 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1557.05 - ₹1604.45, and closed at ₹1563.35.
This is a -1.57% slip from the previous day's closing price.
A total volume of 3,171 shares were traded at the close of the day’s session.
In the last one week, shares of Zydus Wellness Limited have slipped by -3.36%.
Zydus Wellness Limited's Key Ratios
Zydus Wellness Limited has a market cap of ₹103.20 billion, indicating a price to book ratio of 2.1541 and a price to sales ratio of 4.9853.
In the last 12-months Zydus Wellness Limited’s revenue was ₹22.60 billion with a gross profit of ₹10.96 billion and an EBITDA of ₹3.01 billion. The EBITDA ratio measures Zydus Wellness Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Zydus Wellness Limited’s operating margin was 12.44% while its return on assets stood at 3.39% with a return of equity of 6.23%.
In Q2, Zydus Wellness Limited’s quarterly earnings growth was a negative -19.4% while revenue growth was a positive 0.8%.
Zydus Wellness Limited’s PE and PEG Ratio
- Forward PE
- 20.9644
- Trailing PE
- 36.3807
- PEG
Its diluted EPS in the last 12-months stands at ₹44.58 per share while it has a forward price to earnings multiple of 20.9644 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Zydus Wellness Limited’s profitability.
Zydus Wellness Limited stock is trading at a EV to sales ratio of 5.0763 and a EV to EBITDA ratio of 29.5901. Its price to sales ratio in the trailing 12-months stood at 4.9853.
Zydus Wellness Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0.31% and a payout ratio of 11.21%.
Balance sheet and cash flow metrics
- Total Assets
- ₹58.33 billion
- Total Liabilities
- ₹6.92 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 11.21%
Zydus Wellness Limited ended 2024 with ₹58.33 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹58.33 billion while shareholder equity stood at ₹51.23 billion.
Zydus Wellness Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹6.92 billion in other current liabilities, in common stock, ₹14.77 billion in retained earnings and ₹39.20 billion in goodwill. Its cash balance stood at ₹370.40 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.00.
Zydus Wellness Limited’s total current assets stands at ₹9.08 billion while long-term investments were ₹0 and short-term investments were ₹959.90 million. Its net receivables were ₹2.08 billion compared to accounts payable of ₹3.13 billion and inventory worth ₹4.57 billion.
In 2024, Zydus Wellness Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Zydus Wellness Limited paid ₹0.11 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1563.35
- 52-Week High
- ₹1785.1914
- 52-Week Low
- ₹1359.3129
- Analyst Target Price
- ₹
Zydus Wellness Limited stock is currently trading at ₹1563.35 per share. It touched a 52-week high of ₹1785.1914 and a 52-week low of ₹1785.1914. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1528.66 and 200-day moving average was ₹1503.74 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7859.7% of the company’s stock are held by insiders while 1407.5% are held by institutions.
Frequently Asked Questions About Zydus Wellness Limited
Similar Industry Stocks (Packaged Foods)
Most Active
Top Gainers
Top Losers
About
Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon D brand; and Sugarlite, a blended sugar coated with stevia. The company offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and cleansers under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. It exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is based in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Zydus Lifesciences Limited.